Sec Form 3 Filing - Corona Gary Louis @ Medtronic plc - 2024-08-03

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Corona Gary Louis 2. Issuer Name and Ticker or Trading Symbol Medtronic plc [ MDT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Interim CFO (Last) (First) (Middle) 710 MEDTRONIC PARKWAY 3. Date of Earliest Transaction (MM/DD/YY) 08/03/2024 (Street) MINNEAPOLIS, MN55432 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Ordinary Shares 24,069 ( 1 ) ( 2 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to Buy) $ 87.76 07/31/2024( 3 ) 07/31/2033 Ordinary Shares 10,164 D Stock Option (Right to Buy) $ 80 07/29/2025( 3 ) 07/29/2034 Ordinary Shares 1,540 D Performance Share Unit ( 6 ) ( 4 ) ( 4 ) Ordinary Shares 3,245 ( 5 ) D Performance Share Unit ( 6 ) ( 7 ) ( 7 ) Ordinary Shares 3,125 ( 8 ) D Performance Share Unit ( 6 ) ( 9 ) ( 9 ) Ordinary Shares 6,250 ( 10 ) D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Corona Gary Louis 710 MEDTRONIC PARKWAY MINNEAPOLIS, MN55432 Interim CFO Signatures /s/ Thomas L. Osteraas, attorney-in-fact 08/12/2024 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Includes 432 shares purchased pursuant to Medtronic's Employee Stock Ownership Plan. ( 2 )Includes 6,438 restricted stock units that vest in three annual installments beginning on December 6, 2024; 4,249 restricted stock units that vest on July 10, 2025; 1,298 restricted stock units that vest on July 31, 2026; and 6,250 restricted stock units that vest on July 29, 2027. ( 3 )These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. ( 4 )The performance share units vest on April 24, 2026. ( 5 )The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 3,245 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. ( 6 )Each performance share unit represented a contingent right to receive one share of Medtronic common stock. ( 7 )The performance share units vest on December 6, 2026. ( 8 )The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 3,125 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. ( 9 )The performance share units vest on April 30, 2027. ( 10 )The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 6,250 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.